Tsiligianni, Ioanna
Rodríguez, Miguel Román
Lisspers, Karin
LeeTan, Tze
Infantino, Antonio
Article History
Received: 26 August 2016
Revised: 8 December 2016
Accepted: 9 December 2016
First Online: 15 February 2017
Competing interests
: I.T. has received honoraria for educational activities, speaking engagements and advisory boards from Boehringer Ingelheim, Novartis, AstraZeneca, and GlaxoSmithKline. M.R.R. has received honoraria for educational activities, speaking engagements and advisory boards from Boehringer Ingelheim, Rovi, Teva, Chiesi, Menarini, Pfizer, Novartis, AstraZeneca, and GlaxoSmithKline. K.L. has received payments for educational activities and speaking engagemnets from AstraZeneca, GlaxoSmithKline, Meda, M.S.D., Novartis, and Nycomed and has served on advisory boards arranged by Novartis and Meda. T.L.T. has received honoraria for educational activities, speaking engagements, and advisory boards from Boehringer Ingelheim, Novartis, AstraZeneca, Mundipharma, Chiesi, GlaxoSmithKline, Merck Sharpe & Dohme, Sanofi, and Janssen. A.I. declares no competing interests.